CNMD News Alert Conmed Corp (CNMD) 45.33 12/25/2014 12:35:03

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Conmed Corp (CNMD) 45.33 $CNMD

CONMED Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - Thu Dec 11, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery, announced today that the Company will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 8:30 AM Pacific Time. The event will be held in San Francisco at the Westin St. Francis Hotel.
JPM: 62.48 (unch), CNMD: 45.33 (+0.42)

CONMED Corporation Announces Management Transitions
GlobeNewswire - Tue Dec 09, 8:12AM CST
Robert Shallish to Retire as Executive VP, Finance and CFO Effective March 31, 2015; Luke Pomilio Appointed Executive VP, Finance and CFO Effective April 1, 2015
CNMD: 45.33 (+0.42)

Insider Trading Alert - CNMD, FRM And LTC Traded By Insiders
at The Street - Fri Nov 21, 1:15PM CST
Stocks with insider trader activity include CNMD, FRM and LTC
FRM: 7.61 (unch), CNMD: 45.33 (+0.42), LTC: 42.71 (+0.05)

CONMED Corporation to Present at the 26th Annual Piper Jaffray Healthcare Conference
Marketwired - Thu Nov 20, 3:15PM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery, announced today that the Company will participate in the 26th Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014 at 2:30 PM Eastern Time. The event will be held in New York City at the New York Palace Hotel.
CNMD: 45.33 (+0.42)

CONMED Corporation Announces Quarterly Cash Dividend
Marketwired - Wed Nov 19, 3:54PM CST
CONMED Corporation (NASDAQ: CNMD) announced today that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2015 to all shareholders of record as of December 15, 2014. Annualized, the dividend rate is equivalent to $0.80 per share, yielding approximately 2.0% at current share prices.
CNMD: 45.33 (+0.42)

CONMED Corporation declares $0.20 dividend
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 3:54PM CST

CNMD: 45.33 (+0.42)

Conmed Earnings In Retrospect: Up 4.4% in the Last 18 Days (CNMD)
Comtex SmarTrend(R) - Mon Nov 10, 11:51AM CST
When Conmed (NASDAQ:CNMD) reported earnings 18 days ago on October 23rd, 2014, analysts, on average, expected the company to report earnings of $0.39 on sales of $173.5 million. Conmed actually reported earnings of $0.44 per share on sales of $175.0 million, beating EPS estimates by $0.05 and beating revenue estimates by $1.5 million. Shares of Conmed have climbed from $40.02 to $41.77, representing a gain of 4.4% since the company reported earnings 18 days ago.
CNMD: 45.33 (+0.42)

Curt Hartman Named President and CEO of CONMED Corporation
GlobeNewswire - Mon Nov 10, 6:07AM CST
CONMED Corporation (Nasdaq:CNMD) today announced that its Board of Directors has appointed Curt Hartman as President and Chief Executive Officer, effective immediately. Mr. Hartman joined the Company's Board of Directors in March 2014 and was appointed Interim Chief Executive Officer in July 2014.
CNMD: 45.33 (+0.42)

Computer Assisted Surgical (CAS) Systems - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/46xq77/computer_assisted) has announced the addition of the "Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Computer Assisted Surgical (CAS) Systems in US$ by the following Product Segments: - Surgical Planners and Simulators - Surgical Navigation Systems - Surgical Robots The report profiles 56 companies including many key and niche players such as: - 3D Systems Corporation - Accuray, Inc. - B. Braun Melsungen AG - Brainlab AG - CAE, Inc. - CONMED Corporation - Curexo Technology Corporation - Hansen Medical, Inc. - Intuitive Surgical, Inc. - Medtronic, Inc. - Mazor Robotics Ltd. - Northern Digital Inc. - Polhemus, Inc. - Simbionix USA Corp. - Stryker Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Surgical Robots Market - A Review 3. An Insight Into Surgical Planners & Simulators Market 4. Surgical Navigation Systems Market 5. Product Overview 6. Cas In Select Medical Domains 7. Product Introductions/Innovations/ Approvals 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 56 (including Divisions/Subsidiaries - 57) - The United States (38) - Canada (3) - Japan (1) - Europe (14) - - France (1) - - Germany (6) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/46...r_assisted
ISRG: 530.94 (+4.78), MDT: 74.08 (+0.31), HNSN: 0.55 (-0.02), DDD: 30.54 (-0.64), CNMD: 45.33 (+0.42), MZOR: 13.01 (-0.68), ARAY: 7.54 (+0.19), SYK: 96.00 (-0.61)

CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 66.76 (+0.85), CNMD: 45.33 (+0.42), COO: 164.19 (+0.99)

CONMED (CNMD) CEO Curt Hartman on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 8:50PM CDT

CNMD: 45.33 (+0.42)

Conmed affirms guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:16PM CDT

CNMD: 45.33 (+0.42)

Conmed posts 3Q profit
Automated Insights - Thu Oct 23, 4:57PM CDT
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Thursday reported profit of $2 million in its third quarter.
CNMD: 45.33 (+0.42)

CONMED beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 3:39PM CDT

CNMD: 45.33 (+0.42)

CONMED Corporation Announces Third Quarter 2014 Financial Results
Marketwired - Thu Oct 23, 3:06PM CDT
CONMED Corporation (NASDAQ: CNMD)
CNMD: 45.33 (+0.42)

BMTC, SSD, MCBC, SPNC, CNMD, HBHC Expected To Be Down After Next Earnings Releases
M2 - Thu Oct 23, 3:34AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, October 23rd 2014 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and October earnings reports. Bryn Mawr Bank Corp (NASDAQ:BMTC), Simpson Manufacturing Co Inc (NYSE:SSD), Macatawa Bank Corp (NASDAQ:MCBC), Spectranetics Corp (NASDAQ:SPNC), CONMED CORPORATION (NASDAQ:CNMD), Hancock Holding Co (NASDAQ:HBHC) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:
SPNC: 34.50 (+0.59), CNMD: 45.33 (+0.42), HBHC: 30.64 (-0.36), MCBC: 5.48 (+0.07), SSD: 34.41 (+0.17), BMTC: 30.97 (+0.14)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:35PM CDT

MXIM: 31.97 (+0.31), GHL: 43.02 (-0.18), HBHC: 30.64 (-0.36), HWAY: 19.88 (+0.13), DV: 48.89 (-0.04), FET: 21.30 (+0.42), CLNE: 5.25 (-0.15), ADES: 20.77 (+0.15), FII: 33.86 (+0.26), LOGM: 49.70 (-0.52), MSFT: 48.14 (-0.31), BLDR: 6.64 (-0.05), CLMS: 13.48 (+0.04), PDFS: 14.97 (+0.03), IM: 27.99 (-0.20), NCR: 29.59 (+0.05), EW: 130.75 (+1.17), POL: 38.64 (+0.39), DLB: 43.88 (+0.11), HUBG: 37.58 (-0.07), PFPT: 49.59 (-0.13), PFG: 53.07 (-0.25), NTGR: 36.00 (+0.15), PCCC: 25.68 (+0.69), FSL: 25.48 (unch), CTCT: 38.11 (+0.51), BMRN: 88.18 (+0.89), RUBI: 17.00 (+0.08), OLN: 22.77 (+0.10), ALTR: 37.97 (+0.23), CB: 104.37 (-0.07), N: 111.45 (-0.43), MTSN: 3.53 (-0.03), JNPR: 22.83 (+0.02), MXWL: 9.40 (-0.03), GIMO: 17.43 (+0.32), INFA: 38.92 (+0.17), ELY: 7.23 (+0.01), P: 18.02 (-0.31), RMD: 57.39 (+0.40), CNMD: 45.33 (+0.42), BJRI: 49.15 (+0.22), PEB: 46.54 (+0.18), CERN: 65.10 (-0.21), CBI: 41.94 (-0.17), AMZN: 303.03 (-3.26), ECHO: 29.68 (-0.21), ALGN: 57.01 (+0.17), LSCC: 6.85 (+0.05), DECK: 90.95 (-1.01), CYN: 80.87 (-0.35), PACB: 7.46 (+0.01), QLIK: 31.77 (+0.24), CPWR: 10.35 (+0.01), FLS: 60.00 (-0.21), BAS: 7.30 (-0.08), KLAC: 72.02 (-0.61)

Global Orthopedic Trauma Fixation Devices Market Outlook 2020: DePuy Synthes Dominates with a 47% Market Share
M2 - Thu Oct 09, 2:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4qdpc9/orthopedic_trauma) has announced the addition of the "Orthopedic Trauma Fixation Devices Market - Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020" report to their offering. The global orthopedic trauma fixation devices market is witnessing significant growth due to increasing incidence of fractures and lack of substitutes. Major driving factors for the orthopedic trauma fixation devices market are increase in the elderly population, growing healthcare costs, and rising prevention measures for various orthopedic-related problems. Increasing participation in sports and rising number of road accidents are the leading causes for orthopedic trauma fracture cases. Growing demand for better facilities in orthopedic trauma surgeries, and increasing investments by governments and multinational companies has enabled the growth of the orthopedic trauma fixation devices market. On the basis of the type of fixator, internal fixators have the largest market share in the orthopedic trauma fixation devices market. On the basis of shape and size, orthopedic trauma internal fixators can be classified into intramedullary nails, intramedullary screws and plate and screw systems. For the treatment of orthopedic trauma, various types of fixators can be used, depending upon the nature and severity of the fracture. Fixator may be made of metallic or bioabsorbable material. This report forecasts future potential of orthopedic trauma fixation devices market and analyses drivers and opportunities, restraints and challenges, market trends, Porter's forces, competitive landscape and company profiles of key players. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Orthopedic Trauma Fixators - Industry Analysis Chapter 4 Market Trends Chapter 5 Porter's Five Force Analysis Chapter 6 Market Segmentation by Type of Fixator Chapter 7 Market Segmentation by Type of Internal Fixator Chapter 8 Market Segmentation by Composition Chapter 9 Market Segmentation by Region Chapter 10 Competitive Benchmarking Chapter 11 Company Profiles - Arthrex, Inc. - B. Braun Melsungen AG - CONMED - Integra LifeSciences Holdings Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Orthofix Holding Inc. - Smith & Nephew - Stryker Corporation - Tornier, Inc. - Wright Medical Technology, Inc - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/4q...dic_trauma
ZMH: 114.11 (+0.64), SNN: 38.18 (+0.14), JNJ: 104.59 (+0.31), IART: 53.68 (+0.32), MDT: 74.08 (+0.31), CNMD: 45.33 (+0.42), SYK: 96.00 (-0.61)

CONMED Corporation to Announce Third Quarter 2014 Financial Results on October 23, 2014
Marketwired - Wed Oct 08, 6:00AM CDT
CONMED Corporation (NASDAQ: CNMD) announced today that it will report third quarter 2014 financial results at 4:00 PM Eastern time on Thursday, October 23, 2014, and will also hold a conference call at 4:30 PM Eastern Time that same day to discuss the results.
CNMD: 45.33 (+0.42)

Global Regenerative Medicine (Bone and Joint) Market Forecasts and Opportunities, 2019
M2 - Wed Oct 08, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5879mp/regenerative) has announced the addition of the "Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019 U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. The global market for regenerative medicine bone and joint application is dominated by various bone graft substitute in 2012. However, it is expected that tissue engineering will become a lucrative market in future. Factors such as growing geriatric population, favorable government support and increasing bone and joint reconstructive surgeries accentuate growth of the global regenerative medicine bone and joint application market. Scope of the Report The global regenerative medicine (bone and joint) market is segmented as follows: - Regenerative Medicine (Bone and Joint) Market, by Technology - Stem Cell Therapy - Biomaterial - Tissue Engineering Regenerative Medicine (Bone and Joint) Market, by Application - Bone Graft Substitutes - Osteoarticular Diseases - Allogeneic Bones - Autogenic Bones - Others Major market players profiled in this report includes: - Anika Therapeutics, Inc - Arthrex, Inc - Baxter International, Inc. - CONMED Corporation - DePuy Synthes, Inc. - Medtronic, Inc. - Smith & Nephew PLC - Stryker Corporation - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/58...generative
ZMH: 114.11 (+0.64), SNN: 38.18 (+0.14), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04), CNMD: 45.33 (+0.42), ANIK: 38.26 (+0.73), SYK: 96.00 (-0.61)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 22

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 160

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 58

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Appian Survey Flags AI Aloneware Maintenance Drag Risk

Updated Category News Views 58

A bot can spit out a feature before lunch, then leave a repair bill nobody budgeted for. That is the uncomfortable issue behind Appian's new research on AI-assisted software development: speed is easy to celebrate, while ownership gets shoved into a dark corner until something breaks. Appian said on November 20, 2026, that two-thirds of surveyed AI decision-makers and IT...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
Mobile Core's Cost Crunch Favors Telecom's Big Three

Updated Category News Views 67

Server bills have finally crashed the party in mobile core, and nobody should pretend that is a minor inconvenience. Dell'Oro Group's 3Q 2026 read is blunt: Mobile Core Network revenue growth was lackluster because 5G spending came in below expectations, while higher server costs pushed operators to reshuffle priorities, postpone projects, and keep 4G core gear alive...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 76

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading

Top 5 Most Recently Viewed Articles

Gate Ventures Backs Japanese Web3 Gaming Innovator double jump.tokyo

Updated Category News Views 276

Gate Ventures Invests in double jump.tokyo Gate Ventures is making a significant impact in the blockchain and gaming sectors with its latest investment in double jump.tokyo Inc., a prominent player in Web3 gaming based in Japan. This strategic investment is part of a larger $10 million funding round led by SBI Investment. This backing represents more than just financial...

Continue Reading
Insights from Gridwise's Gig Mobility Report Highlight Trends

Updated Category News Views 1754

Gridwise Annual Gig Mobility Report Highlights The gig mobility industry is encountering significant challenges as economic conditions evolve. Consumers are feeling the pinch from rising prices, leading to resistance against fare increases. Moreover, driver wages are stagnating, which is causing utilization rates to remain low. As platforms strive for profitability, this...

Continue Reading
Esquire Financial Achieves Historic Stock Surge to $81.89

Updated Category News Views 124

Esquire Financial's Stock Reaches New Heights Esquire Financial Holdings Inc (NASDAQ: ESQ) has celebrated a remarkable achievement as its stock price reached an all-time high of $81.89 recently. This milestone reflects the company's strong financial health and market position, boasting a market capitalization of approximately $638 million. The surge in price signals a...

Continue Reading
Deck Commerce Shines as a Leader in Omnichannel Management

Updated Category News Views 199

Deck Commerce Emerges as a Leading Innovator In the competitive landscape of order management systems, Deck Commerce stands out as a beacon of innovation and excellence. Recently recognized by QKS Group's SPARK Matrix™ for 2025, the company has secured its position as both a leader and emerging innovator in the field. This accolade reflects Deck Commerce's dedication to...

Continue Reading
Porsche Penske Motorsport Celebrates Historic Victory

Updated Category News Views 343

Porsche Penske Motorsport Celebrates Historic Victory Porsche Penske Motorsport has achieved remarkable success at the prestigious 24 Hours of Daytona, clinching its second consecutive win. As the race unfolded, the familiar faces of Felipe Nasr, Nick Tandy, and Laurens Vanthoor led the No. 7 Porsche 963 to victory, marking a milestone as Porsche secured its 20th overall...

Continue Reading